Skip to main content
Fig. 4 | BMC Oral Health

Fig. 4

From: Development of a novel denture care agent with highly active enzyme, arazyme

Fig. 4

Inhibition growth curve of E. faecalis (a), S. epidermis (b), C. albicans (c), and S. mutans (d). To estimate antimicrobial activity, corresponding concentrations (10, 20, 50, 100, and 200 mg/mL) of arazyme were applied to each growth inhibition assay. The treated cells were incubated with shaking, and the optical density at 595 nm of each sample was measured every 3 h for 1 day. Data are presented as means ± SD (n = 3). Statistical significance between compared groups are indicated as * P < 0.05

Back to article page